Most antibiotics need to penetrate their target bacteria. But Darobactin, a newly discovered compound, is much too large to do so. Nonetheless, it kills many antibiotic-resistant pathogens – by exploiting a tiny weak spot on their surface. Researchers at the University of Basel’s Biozentrum have now revealed the amazing mechanism at play and thereby opened the...
